Loading clinical trials...
Loading clinical trials...
All consecutive ACLF (Acute on Chronic Liver failure) patients presenting to the institute of liver and biliary sciences, irrespective of the etiology , who have survived the acute phase (i.e. 90 days...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institute of Liver and Biliary Sciences, India
NCT06948565 · Cirrhosis, Intensive Care Medicine, and more
NCT06340269 · Acute on Chronic Liver Failure, Multiple Organ Failure
NCT06837766 · Acute on Chronic Liver Failure (ACLF)
NCT06285253 · Acute Liver Failure, Acute Liver Injury, Drug Induced, and more
NCT07422948 · Acute on Chronic Liver Failure
Institute of liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions